Document is current
Any future updates will be listed below
-
Authors
Miroshnychenko, Anna
Zeraatkar, Dena
Phillips, Mark R. http://orcid.org/0000-0003-0923-261X
Bakri, Sophie J.
Thabane, Lehana http://orcid.org/0000-0003-0355-9734
Bhandari, Mohit http://orcid.org/0000-0001-9608-4808
Chaudhary, Varun http://orcid.org/0000-0002-9988-4146
,
Chaudhary, Varun http://orcid.org/0000-0002-9988-4146
Bhandari, Mohit http://orcid.org/0000-0001-9608-4808
Wykoff, Charles C.
Sivaprasad, Sobha
Thabane, Lehana http://orcid.org/0000-0003-0355-9734
Kaiser, Peter
Sarraf, David
Bakri, Sophie J.
Garg, Sunir J.
Singh, Rishi P.
Holz, Frank G.
Wong, Tien Y.
Guymer, Robyn H.
- License Information
-
More Information
Article History
Received: 26 November 2021
Revised: 30 November 2021
Accepted: 6 December 2021
First Online: 13 January 2022
Competing interests
: SJB: Consultant: Adverum, Allegro, Alimera, Allergan, Apellis, Eyepoint, ilumen, Kala, Genentech, Novartis, Regenexbio, Roche, Zeiss – unrelated to this study. MB: Research funds: Pendopharm, Bioventus, Acumed – unrelated to this study. VC: Advisory Board Member: Alcon, Roche, Bayer, Novartis; Grants: Bayer, Novartis – unrelated to this study. Rest authors have nothing to disclose.
Free to read: This content has been made available to all.
